GFAP Antikörper (Cytosolic, Intracellular)

Produktnummer ABIN7886319

Dieser Meerschweinchen Polyklonal Antikörper detektiert spezifisch GFAP in WB und IHC. Es zeigt Reaktivität gegenüber Proben von Ratte.

Kurzübersicht für GFAP Antikörper (Cytosolic, Intracellular) (ABIN7886319)

Target: GFAP (Glial Fibrillary Acidic Protein (GFAP))

Reaktivität: Ratte

Wirt: Meerschweinchen

Klonalität: Polyklonal

Konjugat: Dieser GFAP Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Produktdetails anti-GFAP Antikörper

Bindungsspezifität: AA 27-39, Cytosolic, Intracellular

Verwendungszweck: A Guinea Pig Polyclonal Antibody to GFAP

Kreuzreaktivität: Maus, Ratte

Kreuzreaktivität (Details): The antibody will not recognize GFAP from human samples.

Homologie: Mouse - 10,13 amino acid residues identical The antibody will not recognize GFAP from human samples

Produktmerkmale: Intracellular

Aufreinigung: Affinity purified on immobilized antigen.

Immunogen: (C)RHLGTIPRLSLSR, corresponding to amino acid residues 27-39 of rat Glial fibrillary acidic protein

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

WB: 1:500

FC: The optimal concentration should be determined by the user

ICC: The optimal concentration should be determined by the user

IHC: 1:600-1:1200

IP: The optimal concentration should be determined by the user

Kommentare:

Negative Control: (ABIN7235599)

Blocking Peptide: (ABIN7235599)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: 25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

Konzentration: 0.8 mg/mL

Buffer: PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C

Details zu GFAP

Target: GFAP (Glial Fibrillary Acidic Protein (GFAP))

Andere Bezeichnung: GFAP

Hintergrund:

Synonyms: Glial fibrillary acidic protein

Description: Glial fibrillary acidic protein (GFAP) is a key intermediate filament (IF) III protein responsible for maintaining the mechanical strength of glia cells by supporting their cytoskeleton structure. GFAP is expressed in astrocytes in the CNS, non-myelinating Schwann cells in the PNS, and enteric glial cells1.GFAP has a structural organization that is typical to class III IF proteins: it has a head, rod, and tail domains. The N-terminal head domain is important for filament formation and the C-terminal domain is important for oligomerization2.GFAP is encoded by a single gene mapped to human chromosome 17q21. To date, 10 isoforms/splice variants have been identified. GFAP is tightly regulated: both at mRNA transcription level and by phosphorylation and other post-translational modifications. A number of growth factors such as CNTF, FGF and TGF-β can induce GFAP gene transcription activation leading to increased GFAP protein levels3.Single nucleotide polymorphism (SNP) in GFAP results in the formation of Rosenthal fibers that cause Alexander Disease, hence, GFAP is a potential drug target for the treatment of this disease. A number of GFAP mutations were found in the coding and in the promoter regions of Alexander disease patients4.GFAP gene activation and protein induction appear to play a critical role in astroglia cell activation (astrogliosis) following CNS injuries and neurodegeneration. GFAP protein and its breakdown products are rapidly released into biofluids following traumatic brain and spinal cord injuries and stroke, making them strong candidate biomarkers for such neurological disorders5.

Gen-ID: 24387

NCBI Accession: NM_002055

UniProt: P47819